Related Experiment Videos
Monoterpene biosynthesis pathway construction in Escherichia coli
Ora A Carter1, Reuben J Peters, Rodney Croteau
1Institute of Biological Chemistry, and Plant Physiology Program, Washington State University, Pullman, WA 99164-6340, USA.
Phytochemistry
|August 29, 2003
Summary
Engineered E. coli produced (-)-limonene from isoprenoid precursors. Downstream conversion to (-)-carvone was limited by precursor supply and cellular transport, highlighting challenges in microbial biosynthesis of spearmint compounds.
Area of Science:
- Metabolic Engineering
- Synthetic Biology
- Microbial Biotechnology
Background:
- (-)-Carvone is a valuable spearmint monoterpene ketone with applications in flavor and fragrance industries.
- Microbial production offers a sustainable alternative to plant extraction.
- Efficient biosynthesis pathways in microbial hosts remain a challenge.
Purpose of the Study:
- To engineer Escherichia coli for the biosynthesis of (-)-carvone.
- To investigate the limiting factors in the microbial production of carvone and its intermediates.
- To assess the functionality of downstream enzymes in the carvone pathway.
Main Methods:
- Constructed a synthetic pathway in E. coli by introducing four genes for (-)-carvone biosynthesis.
- Utilized inducible gene overexpression for pathway component production.
- Analyzed pathway intermediates and enzyme activity.
- Performed feeding studies with (-)-limonene to evaluate downstream conversion.
Main Results:
- Achieved production of ~5 mg/l of (-)-limonene, which was excreted into the medium.
- Downstream products (-)-carveol and (-)-carvone were not detected under initial overexpression conditions.
- Enzyme assays revealed limited flux due to C(5) isoprenoid precursor availability.
- Feeding studies confirmed enzyme functionality but showed compromised efficiency due to uptake/trafficking issues.
Conclusions:
- The engineered E. coli can produce (-)-limonene, but precursor supply is a major bottleneck.
- Downstream conversion to (-)-carvone is hindered by both precursor limitations and cellular transport restrictions.
- Further optimization requires addressing isoprenoid precursor pool enhancement and improving substrate uptake/trafficking mechanisms.